IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
-5.26%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$329M
AUM Growth
+$329M
(-5.9%)
Cap. Flow
+$40M
Cap. Flow
% of AUM
12.16%
Top 10 Holdings %
Top 10 Hldgs %
37.77%
Holding
184
New
15
Increased
124
Reduced
12
Closed
9
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$8.27M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.11M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$6.52M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$6.34M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$5.94M |
Top Sells
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$11.3M |
| 2 |
Biogen
BIIB
|
$6M |
| 3 |
BCYC
Bicycle Therapeutics
BCYC
|
$5.89M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$3.95M |
| 5 |
iShares Biotechnology ETF
IBB
|
$3.67M |
Sector Composition
| 1 | Healthcare | 98.75% |
| 2 | Consumer Staples | 0.62% |
| 3 | Technology | 0.36% |
| 4 | Financials | 0.23% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Protara Therapeutics
TARA
$125M
| $1.52M | 0.2% |
296,426
+17,170
| +6% | +$87.8K |
|
|
RNTX
52
Rein Therapeutics, Inc. Common Stock
RNTX
$29M
| $1.49M | 0.2% |
145,104
+6,925
| +5% | +$71K |
|
|
RCOR
53
DELISTED
Renovacor, Inc.
RCOR
| $1.46M | 0.19% |
343,283
+381
| +0.1% | +$1.62K |
|
54
MacroGenics
MGNX
$121M
| $1.45M | 0.19% |
164,119
+8,072
| +5% | +$71.1K |
|
55
Eledon Pharmaceuticals
ELDN
$155M
| $1.43M | 0.19% |
362,537
+17,959
| +5% | +$70.8K |
|
56
Merus
MRUS
$5.04B
| $1.42M | 0.19% |
53,703
+2,796
| +5% | +$73.9K |
|
|
NTBL
57
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $1.4M | 0.18% |
23,736
+1,141
| +5% | +$67.5K |
|
|
CMMB
58
Chemomab Therapeutics
CMMB
$15.7M
| $1.29M | 0.17% |
67,026
+710
| +1% | +$13.7K |
|
59
Synlogic
SYBX
$17.4M
| $1.25M | 0.16% |
34,652
+2,397
| +7% | +$86.3K |
|
60
Anebulo Pharmaceuticals
ANEB
$101M
| $1.23M | 0.16% |
181,199
+8,890
| +5% | +$60.1K |
|
|
TAOX
61
Tao Synergies Inc. Common Stock
TAOX
$20.9M
| $1.19M | 0.16% |
6,129
+304
| +5% | +$58.8K |
|
|
BLCM
62
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.13M | 0.15% |
523,348
+26,592
| +5% | +$57.5K |
|
63
Nuvation Bio
NUVB
$1.08B
| $1.12M | 0.15% |
213,310
+13,310
| +7% | +$70K |
|
64
Aurinia Pharmaceuticals
AUPH
$1.58B
| $1.08M | 0.14% |
87,071
+4,736
| +6% | +$58.6K |
|
65
Phathom Pharmaceuticals
PHAT
$843M
| $1.07M | 0.14% |
78,550
+3,990
| +5% | +$54.3K |
|
66
CASI Pharmaceuticals
CASI
$36.1M
| $1.07M | 0.14% |
132,016
+9,709
| +8% | +$78.5K |
|
|
DBVT
67
DBV Technologies
DBVT
$249M
| $1.05M | 0.14% |
31,694
+683
| +2% | +$22.6K |
|
68
Ascendis Pharma
ASND
$12.1B
| $1.03M | 0.14% |
8,763
+363
| +4% | +$42.6K |
|
|
BCLI
69
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $1.02M | 0.13% |
20,277
+974
| +5% | +$49.1K |
|
70
MaxCyte
MXCT
$147M
| $964K | 0.13% |
137,958
+7,958
| +6% | +$55.6K |
|
71
Verastem
VSTM
$585M
| $956K | 0.13% |
56,502
+3,388
| +6% | +$57.3K |
|
72
Corvus Pharmaceuticals
CRVS
$419M
| $837K | 0.11% |
510,126
+27,516
| +6% | +$45.1K |
|
|
ISEE
73
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $825K | 0.11% |
49,099
+2,580
| +6% | +$43.4K |
|
|
BLSA
74
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $762K | 0.1% |
77,274
+3,485
| +5% | +$34.4K |
|
|
HEPA
75
DELISTED
Hepion Pharmaceuticals
HEPA
| $751K | 0.1% |
582
+29
| +5% | +$37.4K |
|